Physician profile
Falgooni Patel
NPI 1457659369
$1,280.58
in general payments reported to CMS, 2019-2025
13 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.19 · 2020: $95.95 · 2021: $209 · 2022: $25.42 · 2023: $236 · 2024: $380 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $295.91 | 2019-2025 | Bexsero |
| Cranial Technologies, INC | $275.09 | 2019-2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $265.54 | 2023-2025 | Ycanth |
| Seqirus USA INC | $107.23 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent |
| Pfizer INC. | $72.23 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $71.40 | 2024-2025 | Gardasil 9, Enflonsia, Vaxelis |
| Sobi, INC | $45.21 | 2023 | |
| Phadia US INC. | $34.32 | 2023-2024 | Immunocap |
| Astrazeneca Pharmaceuticals LP | $31.76 | 2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $26.21 | 2023 | |
| Biogen, INC. | $20.55 | 2019 | |
| Hologic Sales and Service, LLC | $18.73 | 2023 | Aptima, Thinprep 2000 Processor |
| Kowa Pharmaceuticals America, INC. | $16.40 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Falgooni Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.